- Home
- PRKS vs MLTX Comparison
PRKS vs MLTX Comparison
Compare PRKS & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRKS
- MLTX
- Stock Information
- Founded
- PRKS 1959
- MLTX 2021
- Country
- PRKS United States
- MLTX Switzerland
- Employees
- PRKS N/A
- MLTX N/A
- Industry
- PRKS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- MLTX Biotechnology: Pharmaceutical Preparations
- Sector
- PRKS Health Care
- MLTX Health Care
- Exchange
- PRKS Nasdaq
- MLTX Nasdaq
- Market Cap
- PRKS 2.8B
- MLTX 2.8B
- IPO Year
- PRKS 2013
- MLTX N/A
- Fundamental
- Price
- PRKS $50.61
- MLTX $51.18
- Analyst Decision
- PRKS Buy
- MLTX Strong Buy
- Analyst Count
- PRKS 11
- MLTX 7
- Target Price
- PRKS $57.73
- MLTX $74.83
- AVG Volume (30 Days)
- PRKS 1.1M
- MLTX 732.8K
- Earning Date
- PRKS 11-06-2025
- MLTX 11-06-2025
- Dividend Yield
- PRKS N/A
- MLTX N/A
- EPS Growth
- PRKS N/A
- MLTX N/A
- EPS
- PRKS 3.77
- MLTX N/A
- Revenue
- PRKS $1,707,446,000.00
- MLTX N/A
- Revenue This Year
- PRKS $0.97
- MLTX N/A
- Revenue Next Year
- PRKS $2.30
- MLTX N/A
- P/E Ratio
- PRKS $13.47
- MLTX N/A
- Revenue Growth
- PRKS N/A
- MLTX N/A
- 52 Week Low
- PRKS $37.68
- MLTX $31.42
- 52 Week High
- PRKS $60.83
- MLTX $61.87
- Technical
- Relative Strength Index (RSI)
- PRKS 46.78
- MLTX 38.79
- Support Level
- PRKS $49.66
- MLTX $51.45
- Resistance Level
- PRKS $52.38
- MLTX $61.30
- Average True Range (ATR)
- PRKS 1.58
- MLTX 2.88
- MACD
- PRKS -0.38
- MLTX -0.85
- Stochastic Oscillator
- PRKS 13.03
- MLTX 3.08
About PRKS United Parks & Resorts Inc. Common Stock
United Parks & Resorts Inc is an American theme park and entertainment company. Its core business is the operation of theme parks and entertainment facilities involving sea animals across the country under prominent brands such as SeaWorld, Busch Gardens, Aquatica, Discovery Cove, and Sesame Place. The company generates the majority of its revenue from selling admission tickets for its theme parks.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.